2'-Hydroxyflavanone: A novel strategy for targeting breast cancer

Area of Science:

• Oncology
• Natural Products Chemistry
• Molecular Biology

Background:

• Breast cancer is a prevalent women's cancer influenced by hormonal and cellular signaling.
• Natural phytochemicals offer anti-inflammatory and anti-cancer properties for novel therapeutic strategies.
• Citrus fruit consumption is linked to reduced breast cancer risk.

Purpose of the Study:

• To evaluate the efficacy of the citrus flavonoid 2 -hydroxyflavanone (2HF) in targeting breast cancer.
• To investigate the molecular mechanisms underlying 2HF's anti-cancer effects.

Main Methods:

• In vitro studies on breast cancer cell lines assessing survival, clonogenic ability, cell cycle, apoptosis, and migration.
• In vivo studies using a mice xenograft model (MDA-MB-231) to evaluate tumor regression and angiogenesis.
• Western blot and histopathological analyses to examine protein expression levels (RLIP76, Ki67, pAkt, survivin, CDK4, cyclin B1, VEGF, CD31, BAX, BCL-2, BIM, vimentin, fibronectin, E-cadherin).

Main Results:

• 2HF inhibited breast cancer cell survival, clonogenic ability, cell cycle progression, and induced apoptosis.
• 2HF decreased VEGF levels and inhibited cancer cell migration in vitro.
• 2HF administration led to tumor regression in a mice xenograft model, decreasing RLIP76, proliferation markers (Ki67, pAkt, survivin, CDK4, cyclin B1), and angiogenesis (VEGF, CD31).
• 2HF modulated apoptotic proteins (increased BAX, BIM; decreased BCL-2) and reversed mesenchymal-to-epithelial transition markers (decreased vimentin, fibronectin; increased E-cadherin).

Conclusions:

• 2HF demonstrates significant anti-cancer activity against breast cancer cells and tumors.
• The anti-cancer effects of 2HF are mediated by the downregulation of RLIP76 and VEGF, and the regulation of key proliferative, apoptotic, and differentiation proteins.
• 2HF shows strong potential as a basis for developing new breast cancer interventions.